Literature DB >> 26055151

Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target.

Zhenglei Xu1, Bihong Liao, Ru Zhang, Jun Yao, Ruiyue Shi, Lisheng Wang.   

Abstract

3-Phosphoinositide-dependent protein kinase 1 (PDK1) is centrally involved in cancer progression, including proliferation, apoptosis and invasion. However, its expression pattern and possible cellular functions in human colorectal cancer remain unclear. In the present study, we show that PDK1 expression is up-regulated at both mRNA and protein levels in colorectal cancer clinical specimens and cell lines. Transient knockdown of PDK1 suppresses cellular growth, induces cellular apoptosis and causes abnormal cell cycle distribution. Meanwhile, decreased PDK1 level is closely associated with reduced Akt/cyclin D1 activity. Activating AKT activity and reintroducing cyclin D1 expression significantly compromised the oncogenic activity induced by PDK1. Together, our findings elucidate a key role for PDK1 in colorectal cellular functions trigged by the Akt/cyclin D1 pathway, thus providing a novel insight of PDK1 in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26055151     DOI: 10.1007/s12032-015-0645-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  36 in total

Review 1.  The regulation of cell migration by PTEN.

Authors:  N R Leslie; X Yang; C P Downes; C J Weijer
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

2.  PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE.

Authors:  Sophie Pinner; Erik Sahai
Journal:  Nat Cell Biol       Date:  2008-01-20       Impact factor: 28.824

3.  Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1.

Authors:  R A Currie; K S Walker; A Gray; M Deak; A Casamayor; C P Downes; P Cohen; D R Alessi; J Lucocq
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

4.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

5.  Roles of PDK-1 and PKN in regulating cell migration and cortical actin formation of PTEN-knockout cells.

Authors:  Mei Ann Lim; Linda Yang; Yi Zheng; Hong Wu; Lily Q Dong; Feng Liu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

Review 6.  Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells.

Authors:  Dennis W Stacey
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 7.  Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation.

Authors:  Ricardo M Biondi
Journal:  Trends Biochem Sci       Date:  2004-03       Impact factor: 13.807

8.  Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change.

Authors:  Christine C Milburn; Maria Deak; Sharon M Kelly; Nick C Price; Dario R Alessi; Daan M F Van Aalten
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 9.  PDK1, the master regulator of AGC kinase signal transduction.

Authors:  Alfonso Mora; David Komander; Daan M F van Aalten; Dario R Alessi
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

10.  An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.

Authors:  N Ahmed; C Riley; M A Quinn
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  1 in total

1.  SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.

Authors:  Qiwei Jiang; Nana Zheng; Lang Bu; Xiaomei Zhang; Xiaoling Zhang; Yuanzhong Wu; Yaqing Su; Lei Wang; Xiaomin Zhang; Shancheng Ren; Xiangpeng Dai; Depei Wu; Wei Xie; Wenyi Wei; Yasheng Zhu; Jianping Guo
Journal:  Mol Cancer       Date:  2021-08-05       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.